APA (7th ed.) Citation

Limaye, S. A., Haddad, R. I., Cilli, F., Sonis, S. T., Colevas, A. D., Brennan, M. T., . . . Murphy, B. A. (2013). Phase 1b, multicenter, single blinded, placebo‐controlled, sequential dose escalation study to assess the safety and tolerability of topically applied AG013 in subjects with locally advanced head and neck cancer receiving induction chemotherapy. Cancer, 119(24), 4268-4276. https://doi.org/10.1002/cncr.28365

Chicago Style (17th ed.) Citation

Limaye, Sewanti Atul, Robert I. Haddad, Fiona Cilli, Stephen T. Sonis, A. Dimitrios Colevas, Michael T. Brennan, Kenneth S. Hu, and Barbara A. Murphy. "Phase 1b, Multicenter, Single Blinded, Placebo‐controlled, Sequential Dose Escalation Study to Assess the Safety and Tolerability of Topically Applied AG013 in Subjects with Locally Advanced Head and Neck Cancer Receiving Induction Chemotherapy." Cancer 119, no. 24 (2013): 4268-4276. https://doi.org/10.1002/cncr.28365.

MLA (9th ed.) Citation

Limaye, Sewanti Atul, et al. "Phase 1b, Multicenter, Single Blinded, Placebo‐controlled, Sequential Dose Escalation Study to Assess the Safety and Tolerability of Topically Applied AG013 in Subjects with Locally Advanced Head and Neck Cancer Receiving Induction Chemotherapy." Cancer, vol. 119, no. 24, 2013, pp. 4268-4276, https://doi.org/10.1002/cncr.28365.